[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353444-105":59,"doc-detail-353444-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","usp11-deubiquitinates-gata3-to-suppress-the-growth-and-metastasis-of-luminal-type-breast-cancers","USP11 deubiquitinates GATA3 to suppress the growth and metastasis of luminal-type breast cancers","","Luminal breast cancers represent 70%–80% of cases but frequently relapse or lose luminal identity after treatment, leading to aggressive, metastatic disease with unclear underlying mechanisms. This study shows that ubiquitin-specific protease 11 (USP11) restrains proliferation and migration of luminal epithelial and tumor cells in vitro while showing opposite effects on basal-like cells in vivo. USP11 deubiquitinates GATA3, enhancing CDKN1B (p27) and ERα transcription in a GATA3-dependent, deubiquitinase activity manner. USP11 overexpression sensitizes luminal tumors to tamoxifen and correlates with USP11, GATA3, p27, and ERα levels in patient tumors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/usp11-deubiquitinates-gata3-to-suppress-the-growth-and-metastasis-of-luminal-type-breast-cancers/353444/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/usp11-deubiquitinates-gata3-to-suppress-the-growth-and-metastasis-of-luminal-type-breast-cancers/353444.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address in luminal breast cancer?","Question",{"text":113,"@type":114},"Luminal breast cancers often relapse after treatment or lose luminal features, producing poorly differentiated cancers with increased invasiveness and metastasis. The mechanisms maintaining luminal fate and controlling proliferation were largely unclear.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does USP11 affect luminal versus basal-like cancer cells?",{"text":118,"@type":114},"USP11 suppresses proliferation and migration of luminal epithelial and tumor cells in vitro. In vivo, USP11 inhibits luminal tumorigenesis and metastasis but promotes basal-like tumorigenesis.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism links USP11 to GATA3 and downstream gene regulation?",{"text":122,"@type":114},"USP11 deubiquitinates GATA3, which binds and transcriptionally activates CDKN1B (encoding p27). USP11 also stimulates CDKN1B and ESR1 (encoding ERα) transcription in a GATA3-dependent, deubiquitinase activity-dependent manner.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353444,1790174348,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","USP11 deubiquitinates GATA3 to suppress the growth and metastasis of luminal-type breast cancers  \nReceived for publication, February 27, 2026, and in revised form, July 1, 2026 Published, Papers in Press, July 29, 2026 [https://doi.org/10.1016/j.jbc.2026.1](https://doi.org/10.1016/j.jbc.2026.1)13371  \nTao Qian 1, *,‡, Xiong Liu 1,‡, Feng Bai 1,2, Qiyue He 1, Yipei Xu1, Jiayi Zhang1, Shiwen Zhang1, Shaoling Ye 1, Yuchan Wang3, Bin Peng4,5, Kapanova Gulnara5,6, Jasur Rizaev7, Wei-Guo Zhu8, Xingzhi Xu4,5,*, and Xin-Hai Pei 1,9,*  \nFrom the 1Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, International Cancer Center, Marshall Laboratory of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University General Hospital, Shenzhen, Guangdong, China; 2Department of Pathology, Shenzhen University Medical School, Shenzhen, Guangdong, China; 3Gansu Dian Medical Laboratory, Lanzhou, China; 4Guangdong Key Laboratory for Genome Stability & Disease Prevention and International Cancer Center, and 5Shenzhen-Almaty Joint Laboratory for Frontiers in Medical Science (salFMS), Shenzhen University Medical School, Shenzhen, Guangdong, China; 6Department of Health Policy and Organization, Al-Farabi Kazakh National University, Almaty, Kazakhstan; 7Department of Public Health and Healthcare Management, Samarkand State Medical University, Samarkand, Uzbekistan; 8Department of Biochemistry and Molecular Biology, International Cancer Center, and 9Department of Anatomy and Histology, Shenzhen University Medical School, Shenzhen, Guangdong, China  \nReviewed by members of the JBC Editorial Board. Edited by Ceshi Chen  \nLuminal breast cancers account for 70%-80% of total breast cancer cases. More than half of luminal breast cancers either relapse after treatment or lose their luminal features, resulting in poorly differentiated cancers with enhanced invasiveness and metastasis, yet the mechanisms remain largely elusive. In this study, we demonstrated that Ubiquitin-specific protease 11 (USP11) suppresses the proliferation and migration of luminal epithelial and tumor cells in vitro, but not basal-like tumor cells. Consistently, USP11 inhibits luminal tumorigenesis and metastasis, but promotes basal-like tumorigenesis in vivo. Mechanistically, USP11 positively regulates GATA3, p27, and ERα in a deubiquitinase activity-dependent manner. USP11 deubiquitinates GATA3, which subsequently binds to and transcriptionally activates CDKN1B (encoding p27). USP11 stimulates CDKN1B and ESR1 (encoding ERα) transcription ina GATA3-dependent manner. GATA3 knockdown reverses the increase in p27 and ERα and the decrease in cell proliferation and migration induced by USP11 overexpression, and p27 knockdown rescues the proliferative inhibition induced by USP11 or GATA3 overexpression in luminal tumorigenesis. USP11 overexpression sensitizes luminal breast cancer cells to tamoxifen treatment. The expression levels of USP11, GATA3, p27, and ERα are positively correlated with each other in human breast tumors and cell lines. We thus identify a novel USP11-GATA3 axis that governs luminal cell fate and restrains luminal cell proliferation and migration during mammary tumor development and metastasis.  \nBreast cancers are classified by gene expression profiling into five intrinsic subtypes: luminal A, luminal B, HER2-  \n‡ These authors contributed equally to this work.  \n* For correspondence: Tao Qian, [qt95@szu.edu.cn](qt95@szu.edu.cn); Xingzhi Xu, xingzhi.xu@ [szu.edu.cn](szu.edu.cn); Xin-Hai Pei, [peixinhai@szu.edu.cn](peixinhai@szu.edu.cn).  \nenriched, basal-like, and normal-like. Luminal tumors are characterized by estrogen receptor (ER) expression, whereas basal-like tumors are typically ER-negative. Basal-like breast cancers are highly invasive, poorly differentiated, and contain several distinct cell types such as cells that express luminal, basal, and mesenchymal biomarkers (1, 2). Some basal-like breast cancers are thought to orig","cbCaicVaqFtA6LwB","https://ap.wps.com/l/cbCaicVaqFtA6LwB","pdf",23877911,"English","# Background and problem statement\n## Luminal vs basal-like breast cancer characteristics\n# Experimental findings\n## USP11 effects on cell proliferation and migration\n## USP11 roles in tumorigenesis and metastasis in vivo\n# Mechanistic model\n## USP11 deubiquitinates GATA3\n## Activation of CDKN1B (p27) and ERα via GATA3\n# Therapeutic implication\n## Sensitization to tamoxifen","[{\"question\":\"What problem does the study address in luminal breast cancer?\",\"answer\":\"Luminal breast cancers often relapse after treatment or lose luminal features, producing poorly differentiated cancers with increased invasiveness and metastasis. The mechanisms maintaining luminal fate and controlling proliferation were largely unclear.\"},{\"question\":\"How does USP11 affect luminal versus basal-like cancer cells?\",\"answer\":\"USP11 suppresses proliferation and migration of luminal epithelial and tumor cells in vitro. In vivo, USP11 inhibits luminal tumorigenesis and metastasis but promotes basal-like tumorigenesis.\"},{\"question\":\"What mechanism links USP11 to GATA3 and downstream gene regulation?\",\"answer\":\"USP11 deubiquitinates GATA3, which binds and transcriptionally activates CDKN1B (encoding p27). USP11 also stimulates CDKN1B and ESR1 (encoding ERα) transcription in a GATA3-dependent, deubiquitinase activity-dependent manner.\"}]","USP11 deubiquitinates GATA3 to suppress the growth and metastasis of luminal-type breast cancers | PDF",1790105412,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab810f8c1ceb32ff41dc90956c425b91.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c1596f3d93ab05e7c35e38e6080abac.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57c494bca4edc0d3e956a50d5fb6e0fc.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5effe2c84a23ae05418ef13539a3487d.webp",980,1292]